KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $72.8 billion.

  • Bristol Myers Squibb's Total Non-Current Liabilities rose 151.65% to $72.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $72.8 billion, marking a year-over-year increase of 151.65%. This contributed to the annual value of $71.7 billion for FY2024, which is 2108.42% up from last year.
  • As of Q3 2025, Bristol Myers Squibb's Total Non-Current Liabilities stood at $72.8 billion, which was up 151.65% from $72.2 billion recorded in Q2 2025.
  • In the past 5 years, Bristol Myers Squibb's Total Non-Current Liabilities ranged from a high of $75.8 billion in Q1 2024 and a low of $55.6 billion during Q2 2023
  • Its 5-year average for Total Non-Current Liabilities is $65.4 billion, with a median of $66.1 billion in 2021.
  • As far as peak fluctuations go, Bristol Myers Squibb's Total Non-Current Liabilities tumbled by 1302.9% in 2023, and later surged by 3592.26% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Total Non-Current Liabilities stood at $66.0 billion in 2021, then fell by 10.4% to $59.1 billion in 2022, then grew by 0.24% to $59.3 billion in 2023, then grew by 21.08% to $71.7 billion in 2024, then rose by 1.51% to $72.8 billion in 2025.
  • Its Total Non-Current Liabilities was $72.8 billion in Q3 2025, compared to $72.2 billion in Q2 2025 and $70.5 billion in Q1 2025.